Methyl CCNU therapy linked leukemia.
D000328:Adult; D001853:Bone Marrow / Q000473:pathology; D003110:Colonic Neoplasms / Q000188:drug therapy; D005260:Female; D006801:Humans; D007938:Leukemia / Q000139:chemically induced* / Q000473:pathology; D009607:Nitrosourea Compounds / Q000009:adverse effects*; D012673:Semustine / Q000009:adverse effects* / Q000627:therapeutic use
D009607:Nitrosourea Compounds; D012673:Semustine